The weekly litigation news digest is live. Subscribe now

IP Verse

Medical Use Of A Dpp-4 Inhibitor - EP3110449

The patent EP3110449 was granted to Boehringer Ingelheim on Jun 28, 2023. The application was filed on Feb 27, 2015 under application number EP15707338A. The patent is currently recorded with a legal status of "Revoked".

EP3110449

BOEHRINGER INGELHEIM
Application Number
EP15707338A
Filing Date
Feb 27, 2015
Status
Revoked
Jan 10, 2025
Publication Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKMar 28, 2024ELKINGTON AND FIFEADMISSIBLE
POLPHARMAMar 26, 2024HAMM & WITTKOPPADMISSIBLE
WUESTHOFF & WUESTHOFFMar 26, 2024SONNENHAUSERADMISSIBLE
TEVA PHARMACEUTICALSMar 21, 2024VON KAUFFMANNADMISSIBLE
SANDOZMar 13, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP2308878
EXAMINATIONUS2012121530
OPPOSITIONEP3110449
OPPOSITIONUS2012121530
OPPOSITIONWO2004018468
OPPOSITIONWO2005049022
OPPOSITIONWO2007128761
OPPOSITIONWO2010092124
OPPOSITIONWO2012065993
OPPOSITIONWO2015128453

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents